Neuberger Berman Group
COCP icon

Neuberger Berman Group’s Cocrystal Pharma COCP Stock Holding History

Neuberger Berman Group’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.2K Hold
31,886
– – ﹤0.01% 2129
2025
Q4 		$31.2K Hold
31,886
– – ﹤0.01% 2074
2025
Q3 		$39.9K Buy
+31,886
New +$49.2K ﹤0.01% 2004
2025
Q2 		– Sell
-59,271
Closed -$84.2K – 2066
2025
Q1 		$84.2K Buy
+59,271
New +$111K ﹤0.01% 1891

Other funds holding COCP

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TC
T3 Companies New York $76.8M AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Neuberger Berman Group's COCP Position: Q1 2026 in Review

Neuberger Berman Group held its Cocrystal Pharma (COCP) position steady in Q1 2026 at 31,886 shares worth $32.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2129.

Neuberger Berman Group first reported a position in COCP in Q1 2025 and has held it in 4 quarters since. The position peaked at $84.2K in Q1 2025. 26 funds tracked by Wall St. Rank hold COCP as of Q1 2026.

  • Neuberger Berman Group held 31,886 shares of Cocrystal Pharma worth $32.2K as of Q1 2026.
  • Neuberger Berman Group left its Cocrystal Pharma share count unchanged in Q1 2026.
  • Cocrystal Pharma made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #2129 holding.
  • Neuberger Berman Group first reported a position in Cocrystal Pharma in Q1 2025 and has held it in 4 quarters since.
  • Neuberger Berman Group's Cocrystal Pharma position peaked at $84.2K in Q1 2025.
  • 26 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.